Cargando…
Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
BACKGROUND: The World Health Assembly has adopted a global strategy to eliminate cervical cancer. However, neither the optimal pathway nor the corresponding economic and health benefits have been evaluated. We take China as an example to assess the optimal pathway towards elimination and the cost-ef...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927373/ https://www.ncbi.nlm.nih.gov/pubmed/33653331 http://dx.doi.org/10.1186/s12916-021-01930-9 |
_version_ | 1783659655009927168 |
---|---|
author | Xia, Changfa Xu, Xiaoqian Zhao, Xuelian Hu, Shangying Qiao, Youlin Zhang, Yong Hutubessy, Raymond Basu, Partha Broutet, Nathalie Jit, Mark Zhao, Fanghui |
author_facet | Xia, Changfa Xu, Xiaoqian Zhao, Xuelian Hu, Shangying Qiao, Youlin Zhang, Yong Hutubessy, Raymond Basu, Partha Broutet, Nathalie Jit, Mark Zhao, Fanghui |
author_sort | Xia, Changfa |
collection | PubMed |
description | BACKGROUND: The World Health Assembly has adopted a global strategy to eliminate cervical cancer. However, neither the optimal pathway nor the corresponding economic and health benefits have been evaluated. We take China as an example to assess the optimal pathway towards elimination and the cost-effectiveness of tailored actions. METHODS: A validated hybrid model was used to assess the costs and benefits of alternative strategies combining human papillomavirus vaccination, cervical screening, and treatment of pre-invasive lesions and invasive cancer for females with different immunization history. All Chinese females living or projected to be born during 2015–2100, under projected trends in aging, urbanization, and sexual activity, were considered. Optimal strategies were determined by cost-effectiveness efficiency frontiers. Primary outcomes were cervical cancer cases and deaths averted and incremental cost-effectiveness ratios (ICERs). We employed a lifetime horizon from a societal perspective. One-way and probabilistic sensitivity analyses evaluate model uncertainty. RESULTS: The optimal pathway represents an integration of multiple tailored strategies from females with different immunization history. If China adopts the optimal pathway, the age-standardized incidence of cervical cancer is predicted to decrease to fewer than four new cases per 100,000 women (i.e., elimination) by 2047 (95% confidence interval 2043 to 2050). Compared to the status quo, the optimal pathway would avert a total of 7,509,192 (6,922,744 to 8,359,074) cervical cancer cases and 2,529,873 (2,366,826 to 2,802,604) cervical cancer deaths in 2021–2100, with the discounted ICER being $− 339 (− 687 to − 79) per quality-adjusted life-year. CONCLUSIONS: By adopting an optimal pathway from 2021 (namely, the year of the first Chinese Centennial Goals) onwards, cervical cancer could be eliminated by the late 2040s (namely, ahead of the second Chinese Centennial Goals) while saving net economic costs in China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-01930-9. |
format | Online Article Text |
id | pubmed-7927373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79273732021-03-03 Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study Xia, Changfa Xu, Xiaoqian Zhao, Xuelian Hu, Shangying Qiao, Youlin Zhang, Yong Hutubessy, Raymond Basu, Partha Broutet, Nathalie Jit, Mark Zhao, Fanghui BMC Med Research Article BACKGROUND: The World Health Assembly has adopted a global strategy to eliminate cervical cancer. However, neither the optimal pathway nor the corresponding economic and health benefits have been evaluated. We take China as an example to assess the optimal pathway towards elimination and the cost-effectiveness of tailored actions. METHODS: A validated hybrid model was used to assess the costs and benefits of alternative strategies combining human papillomavirus vaccination, cervical screening, and treatment of pre-invasive lesions and invasive cancer for females with different immunization history. All Chinese females living or projected to be born during 2015–2100, under projected trends in aging, urbanization, and sexual activity, were considered. Optimal strategies were determined by cost-effectiveness efficiency frontiers. Primary outcomes were cervical cancer cases and deaths averted and incremental cost-effectiveness ratios (ICERs). We employed a lifetime horizon from a societal perspective. One-way and probabilistic sensitivity analyses evaluate model uncertainty. RESULTS: The optimal pathway represents an integration of multiple tailored strategies from females with different immunization history. If China adopts the optimal pathway, the age-standardized incidence of cervical cancer is predicted to decrease to fewer than four new cases per 100,000 women (i.e., elimination) by 2047 (95% confidence interval 2043 to 2050). Compared to the status quo, the optimal pathway would avert a total of 7,509,192 (6,922,744 to 8,359,074) cervical cancer cases and 2,529,873 (2,366,826 to 2,802,604) cervical cancer deaths in 2021–2100, with the discounted ICER being $− 339 (− 687 to − 79) per quality-adjusted life-year. CONCLUSIONS: By adopting an optimal pathway from 2021 (namely, the year of the first Chinese Centennial Goals) onwards, cervical cancer could be eliminated by the late 2040s (namely, ahead of the second Chinese Centennial Goals) while saving net economic costs in China. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-021-01930-9. BioMed Central 2021-03-03 /pmc/articles/PMC7927373/ /pubmed/33653331 http://dx.doi.org/10.1186/s12916-021-01930-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Xia, Changfa Xu, Xiaoqian Zhao, Xuelian Hu, Shangying Qiao, Youlin Zhang, Yong Hutubessy, Raymond Basu, Partha Broutet, Nathalie Jit, Mark Zhao, Fanghui Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study |
title | Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study |
title_full | Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study |
title_fullStr | Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study |
title_full_unstemmed | Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study |
title_short | Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study |
title_sort | effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927373/ https://www.ncbi.nlm.nih.gov/pubmed/33653331 http://dx.doi.org/10.1186/s12916-021-01930-9 |
work_keys_str_mv | AT xiachangfa effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT xuxiaoqian effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT zhaoxuelian effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT hushangying effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT qiaoyoulin effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT zhangyong effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT hutubessyraymond effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT basupartha effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT broutetnathalie effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT jitmark effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy AT zhaofanghui effectivenessandcosteffectivenessofeliminatingcervicalcancerthroughatailoredoptimalpathwayamodelingstudy |